Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The SCORE-NHL study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with aggressive Stage I to IV non-Hodgkin Lymphoma (NHL). Study participants will undergo research blood collections of up to 60 mL as well as residual tissue collection, collected as part of a standard of care procedure, for use in research. Collected samples and data will be analyzed to evaluate biomarkers associated with development and validation of cancer monitoring and detection assays ("Natera cancer monitoring and detection test(s)").
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Nowa diagnoza agresywnego chłoniaka nieziarniczego (stadium I-IV)
- •Możliwość pobrania próbki tkanki nowotworu do badań
- •Zaplanowane leczenie chemioterapią przez 6 cykli
- •Widoczne zmiany nowotworu w badaniach obrazowych
- •Możliwość pobierania próbek krwi
✗ Disqualifies
- •Rozpoznany chłoniak łagodny, chłoniak Hodgkina lub białaczka limfocytarna
- •Chłoniak z udziałem we krwi lub szpiku kostnym
- •Historia przeszczepu macierzystych lub innych narządów
- •Leczenie raka w ciągu ostatniego roku lub inny aktywny nowotwór
- •Wcześniejsze badania na obecność DNA raka we krwi
- •Równoczesne leczenie testowanym eksperymentalnym lekiem
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 6, 2026
- Sex
- No restrictions
Locations (1)
Natera, Inc.
Austin, United States
Trial contact
SCORE-NHL Study Team
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.